Article Nanodisc offers chance better influenza vaccine The Dutch newspaper, Leidsch Dagblad, published an article on the TTW-grant that the Leiden University…tristan11 April 2018
Article SIDUS® technology enables first clinical study with live attenuated Zika vaccine Batavia Biosciences has, with its know-how developed under the SIDUS® technology, extensive expertise in house…tristan8 December 2017
Article Interview with Alfred Luitjens by Biopharm Batavia Biosciences uses Biopharm's BioSolve as process development software. The software enables us to predict…tristan24 October 2017
Article Tackling the challenges in biosimilar development Yield is still an area that requires significant improvement for many promising recombinant protein and…tristan25 April 2017
Article SIDUS® Technology for viral vector manufacturing Viral vectors are highly valued in many therapeutic fields given the promise of low cost…tristan29 March 2017
Article Why Batavia Biosciences is the Best Biotech Company in the Netherlands Batavia Biosciences was awarded Best Biotech Company of the Netherlands in the NBSA 2016. We aim to…tristan20 January 2017